Veru is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancers. Our strategy is primarily to focus on the clinical development and commercialization of oncology drugs for the management of two of the most prevalent cancers globally – prostate cancer and breast cancer.
Disclaimer: https://verupharma.com/online-privacy-policy/
Disclaimer: https://verupharma.com/online-privacy-policy/
Location: Colombia, Antioquia, Miami
Employees: 201-500
Phone: +1 305-509-6897
Founded date: 1996
Investors 1
| Date | Name | Website |
| - | SWK Holdin... | swkhold.co... |
Mentions in press and media 2
| Date | Title | Description |
| 12.03.2024 | Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss | - |
| 12.04.2022 | Experimental COVID drug reduced deaths in severe cases by 55%, maker claims | More On: pharmaceuticals Several over-the-counter drugs recalled over non-childproof packaging Big Pharma isn’t pulling out of Russia despite Ukraine invasion ‘Pharma Bro’ Martin Shkreli permanently banned from running public companies John... |